Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item

Manufacturing Capabilities

MANUFACTURING CAPABILITIES

McGuff Outsourcing Solutions (MOS) and McGuff Pharmaceuticals, Inc. (MPI) offer full sterile drug manufacturing capabilities including aseptic vial filling, terminal sterilization, method development, analytical testing, environmental monitoring, raw material qualification, and pharmacist-directed 503B oversight. Facilities include refrigerated, controlled-temperature, and light-sensitive storage areas, plus cGMP-compliant shipping for domestic and international distribution.

Terminal Sterilization

Aseptic & Sterile Drug Manufacturing

  • Semi-automated and automated aseptic vial filling
  • ISO-classified cleanrooms designed for 503B sterile operations
  • Controlled environments for temperature-sensitive and light-sensitive sterile drug manufacturing
  • Pharmacist oversight of sterile production processes and cGMP compliance
  • cGMP production aligned with FDA 503B guidance and USP standards
Terminal Sterilization

Terminal Sterilization

  • Validated terminal sterilization cycles for high-assurance sterility
  • Integrated with upstream and downstream quality and production workflows
  • Suitable for a wide range of sterile formulations
Method Development & Analytical Testing

Method Development & Analytical Testing

  • In-house method development and method verification
  • Full-service chemical and microbiological QC testing
  • Release testing and stability study support
  • Documentation managed through controlled quality systems
Environmental & Quality Control Programs

Environmental & Quality Control Programs

  • Complete environmental monitoring program (viable & non-viable)
  • Batch record review and quality release executed by QA/QC
  • Dedicated QEV, QA, QC departments
  • Corporate QA auditor (MCI) providing independent oversight
  • Robust validation and continuous quality improvement systems
Product Development & Raw Material Qualification

Product Development & Raw Material Qualification

  • MOS-led pharmaceutical product development and formulation design
  • Raw material identity verification and supplier qualification
  • High-risk suppliers approved by QA/Regulatory and re-audited annually
  • Process development to ensure batch-to-batch consistency
Packaging, Storage & Distribution

Packaging, Storage & Distribution

  • Refrigerated, controlled-temperature, and light-protective cGMP storage
  • cGMP-compliant shipping area dedicated to finished sterile products
  • Temperature-controlled domestic shipping
  • International shipping capabilities for qualified products and destinations

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President